SCOPUS 정보 검색 플랫폼

Clinical Trials

Volumn 9, Issue 5, 2012, Pages 561-569

Some thoughts on sample size: A Bayesian-frequentist hybrid approach

(2) Lan, K K Gordan a Wittes, Janet T b

a JANSSEN RESEARCH AND DEVELOPMENT (United States)

b University of Iowa (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BAYES THEOREM; CALCULATION; EFFECT SIZE; HUMAN; PARAMETERS; PARAMETRIC TEST; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; SAMPLE SIZE; STUDY DESIGN;

BAYES THEOREM; CLINICAL TRIALS, PHASE II AS TOPIC; CLINICAL TRIALS, PHASE III AS TOPIC; HUMANS; MODELS, STATISTICAL; RESEARCH DESIGN; SAMPLE SIZE;

EID: 84867497553 PISSN: 17407745 EISSN: 17407753 Source Type: Journal
DOI: 10.1177/1740774512453784 Document Type: Article

Times cited : (21)

References (16)

1
- 79551575056
- Trial watch: Phase III trials and submission failures 2007-2010
- Arrowsmith J. Trial watch: Phase III trials and submission failures 2007-2010. Nat Rev Drug Discov. 2011 ; 10: 87
- (2011) Nat Rev Drug Discov , vol.10 , pp. 87
- Arrowsmith, J.¹

2
- 84860121016
- Assumptions of expected benefits in randomized phase III trials evaluating systemic treatments for cancer
- Gan HK, You B, Pond GR, Chen EX. Assumptions of expected benefits in randomized phase III trials evaluating systemic treatments for cancer. J Natl Cancer Inst. 2012 ; 104: 590-8
- (2012) J Natl Cancer Inst , vol.104 , pp. 590-598
- Gan, H.K.¹ You, B.² Pond, G.R.³ Chen, E.X.⁴

3
- 0242268069
- Why do phase III trials of promising heart failure drugs often fail? the contribution of 'regression to the truth'
- Krum H, Tonkin A. Why do phase III trials of promising heart failure drugs often fail? The contribution of 'regression to the truth'. J Card Fail. 2003 ; 9: 364-7
- (2003) J Card Fail , vol.9 , pp. 364-367
- Krum, H.¹ Tonkin, A.²

4
- 77957361080
- Alzheimer's failure raises questions about disease-modifying strategies
- Extance A. Alzheimer's failure raises questions about disease-modifying strategies. Nat Rev Drug Discov. 2010 ; 9: 749-51
- (2010) Nat Rev Drug Discov , vol.9 , pp. 749-751
- Extance, A.¹

5
- 84855454549
- New York: Farrar, Straus and Giroux;
- Kahneman D Thinking, Fast and Slow. New York: Farrar, Straus and Giroux ; 2011: 163.
- (2011) Thinking, Fast and Slow , pp. 163
- Kahneman, D.¹

6
- 33845898530
- Sample size and the probability of a successful trial
- Chuang-Stein C. Sample size and the probability of a successful trial. Pharm Stat. 2006 ; 5: 305-9
- (2006) Pharm Stat , vol.5 , pp. 305-309
- Chuang-Stein, C.¹

7
- 0012863523
- Chichester: Wiley;
- Spiegelhalter DJ, Abrams KR, Myles JP Bayesian Approaches to Clinical Trials and Health-Care Evaluation. Chichester: Wiley ; 2004: 193-4.
- (2004) Bayesian Approaches to Clinical Trials and Health-Care Evaluation , pp. 193-194
- Spiegelhalter, D.J.¹ Abrams, K.R.² Myles, J.P.³

8
- 0022592003
- A predictive approach to selecting the size of a clinical trial, based on subjective clinical opinion
- Spiegelhalter DJ, Freedman LS. A predictive approach to selecting the size of a clinical trial, based on subjective clinical opinion. Stat Med. 1986 ; 5: 1-13
- (1986) Stat Med , vol.5 , pp. 1-13
- Spiegelhalter, D.J.¹ Freedman, L.S.²

9
- 0022644394
- Monitoring clinical trials: Conditional or predictive power?
- Spiegelhalter DJ, Freedman LS, Blackburn PR. Monitoring clinical trials: Conditional or predictive power?. Control Clin Trials. 1986 ; 7: 8-17
- (1986) Control Clin Trials , vol.7 , pp. 8-17
- Spiegelhalter, D.J.¹ Freedman, L.S.² Blackburn, P.R.³

10
- 13544263552
- Relationship between Bayesian and frequentist sample size determination
- Inoue LTY, Berry DA, Parmiagiani G. Relationship between Bayesian and frequentist sample size determination. Am Stat. 2005 ; 59: 1-9
- (2005) Am Stat , vol.59 , pp. 1-9
- Lty, I.¹ Berry, D.A.² Parmiagiani, G.³

11
- 85122716876
- Boca Raton, FL: CRC Press;
- Berry SM, Carlin BP, Lee JJ, Muller P Bayesian Adaptive Methods for Clinical Trials. Boca Raton, FL: CRC Press ; 2010:
- (2010) Bayesian Adaptive Methods for Clinical Trials
- Berry, S.M.¹ Carlin, B.P.² Lee, J.J.³ Muller, P.⁴

12
- 0024994537
- The role of internal pilot studies in increasing the efficiency of clinical trials
- Wittes J, Brittain E. The role of internal pilot studies in increasing the efficiency of clinical trials. Stat Med. 1990 ; 9: 65-72
- (1990) Stat Med , vol.9 , pp. 65-72
- Wittes, J.¹ Brittain, E.²

13
- 0000065971
- Sample size re-estimation without unblinding for normally distributed outcomes with unknown variance
- Gould AL, Shih WJ. Sample size re-estimation without unblinding for normally distributed outcomes with unknown variance. Commun Stat Theory Methods. 1992 ; 21: 2833-53
- (1992) Commun Stat Theory Methods , vol.21 , pp. 2833-2853
- Gould, A.L.¹ Shih, W.J.²

14
- 0032886394
- Modification of sample size in group sequential clinical trials
- Cui L, Hung HM, Wang SJ. Modification of sample size in group sequential clinical trials. Biometrics. 1999 ; 55: 853-7
- (1999) Biometrics , vol.55 , pp. 853-857
- Cui, L.¹ Hung, H.M.² Wang, S.J.³

15
- 0032732411
- Adaptive sample size calculations in group sequential trials
- Lehmacher W, Wassmer G. Adaptive sample size calculations in group sequential trials. Biometrics. 1999 ; 55: 1286-90
- (1999) Biometrics , vol.55 , pp. 1286-1290
- Lehmacher, W.¹ Wassmer, G.²

16
- 84864005445
- Conditional power approach to the evaluation of predictive power
- Lan KKG, Hu P, Proschan MA. Conditional power approach to the evaluation of predictive power. Stat Biopharm Res. 2009 ; 1: 131-6
- (2009) Stat Biopharm Res , vol.1 , pp. 131-136
- Kkg, L.¹ Hu, P.² Proschan, M.A.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.